IRD Q2 2025 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+159.2% YoY

Gross Profit

-$3M-109.0% margin

Operating Income

-$9M-309.0% margin

Net Income

-$7M-257.5% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-34.1%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$896,000

Balance Sheet

Total Assets

$39M

Total Liabilities

$21M

Stockholders' Equity

$17M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$1M	+159.2%
Gross Profit	-$3M	$1M	-382.4%
Operating Income	-$9M	-$8M	-6.9%
Net Income	-$7M	-$8M	+4.4%